Table 1_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.docx by Minyong Choi (22465405)

“…Furthermore, among the inconsistent blood draw timing and analytical methods, we aimed to suggest the most suitable strategies in the clinical setting.…”

Image 4_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…Furthermore, among the inconsistent blood draw timing and analytical methods, we aimed to suggest the most suitable strategies in the clinical setting.…”

Image 3_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…Furthermore, among the inconsistent blood draw timing and analytical methods, we aimed to suggest the most suitable strategies in the clinical setting.…”

Image 2_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…Furthermore, among the inconsistent blood draw timing and analytical methods, we aimed to suggest the most suitable strategies in the clinical setting.…”

Image 5_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…Furthermore, among the inconsistent blood draw timing and analytical methods, we aimed to suggest the most suitable strategies in the clinical setting.…”

Image 6_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tif by Minyong Choi (22465405)

“…Furthermore, among the inconsistent blood draw timing and analytical methods, we aimed to suggest the most suitable strategies in the clinical setting.…”

Image 1_Effectiveness of nirsevimab immunization against RSV infection in preterm infants: a systematic review and meta-analysis.tif by Xiaopeng Wang (1424584)

“…</p>Conclusion<p>Nirsevimab significantly decreases the risk of RSV-related infection in preterm infants and represents a valuable intervention for RSV prevention in this vulnerable population.…”

Data Sheet 1_Cardiovascular outcomes in adult patients with atrial septal defect: a nationwide population-based study.docx by Jue Seong Lee (14992676)

“…ASD closure, whether by surgery or using a device, is associated with a decreased incidence of cardiovascular outcomes in adults. …”

Supplementary file 1_Clinical utility of the PBAC score in quantifying treatment response to hysteroscopy: a retrospective observational study.docx by Ömer Faruk Öz (22702202)

“…Data were analyzed using SPSS version 26, and p < 0.05 was considered statistically significant.</p>Results<p>Of the 327 patients included in the study, 91.1% had a baseline PBAC score ≥100, which significantly decreased following hysteroscopy (mean reduction: 393 points; p < .001). …”

Table 1_Effectiveness of nirsevimab immunization against RSV infection in preterm infants: a systematic review and meta-analysis.xlsx by Xiaopeng Wang (1424584)

“…</p>Conclusion<p>Nirsevimab significantly decreases the risk of RSV-related infection in preterm infants and represents a valuable intervention for RSV prevention in this vulnerable population.…”

Image 2_Effectiveness of nirsevimab immunization against RSV infection in preterm infants: a systematic review and meta-analysis.tif by Xiaopeng Wang (1424584)

“…</p>Conclusion<p>Nirsevimab significantly decreases the risk of RSV-related infection in preterm infants and represents a valuable intervention for RSV prevention in this vulnerable population.…”

Table 1_Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study.docx by Sam Salek (5800727)

“…Background<p>Disease-specific factors associated with decreased quality of life (QoL) in patients with leukemia have not been studied in a large-scale, global, observational study.…”

Polygenic adaptation analysis results for the pairwise and multi-population tests for polygenic adaptation (see Methods). by Olivia A. Gray (20700832)

“…The SNP no. column shows how many SNPS are included in the test at this significance threshold. Significant <i>p</i>-values are highlighted in green (figures for all significant Multi-population tests in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1011570#pgen.1011570.s006" target="_blank">S6 Fig</a>). …”

Data Sheet 1_Hyperbaric oxygen therapy for radiation enteritis and clinical parameters: a systematic review and meta-analysis.docx by Yuhan Wang (595964)

“…</p>Results<p>This study analyzed data from 22 clinical studies involving 1,318 subjects, including six RCTs incorporated into a meta-analysis. Moderate-quality evidence suggested that HBOT could significantly reduce the incidence of RE [OR = 0.32, 95% CI (0.14, 0.72), P = 0.006], particularly showing a significant advantage in decreasing the incidence of grade 3 or higher RE according to the RTOG/EORTC criteria [OR = 0.37, 95% CI (0.17, 0.82), P = 0.01]. …”

Supplementary file 1_Effects of non-HDL-C and statin therapy on mortality in ARDS: a retrospective cohort study.docx by Haiming Hu (12451365)

“…Both univariate (HR, 0.48; 95% CI, 0.41–0.58; p < 0.001) and multivariate (HR, 0.49; 95% CI, 0.41–0.58; p < 0.001) Cox regression analyses revealed that statin therapy significantly decreased short-term mortality. Subsequent subgroup analyses further indicated that the beneficial effect of statins was more evident in patients with elevated non-HDL-C levels.…”

Supplementary file 2_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx by Yi-Chang Zhao (14080107)

“…Adverse reactions showed a non-significant reduction (RR = 0.65; 95% CI: 0.38–1.11). …”

Supplementary file 1_The efficacy of resveratrol in the treatment of liver fibrosis: a systematic review and meta-analysis of preclinical studies.docx by Dehua Luo (22275916)

“…</p>Results<p>Resveratrol markedly attenuated collagen deposition and reduced hydroxyproline levels, a central marker of fibrotic progression. It significantly inhibited the accumulation of extracellular matrix components and modulated profibrotic mediators. …”

Supplementary file 5_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx by Yi-Chang Zhao (14080107)

“…Adverse reactions showed a non-significant reduction (RR = 0.65; 95% CI: 0.38–1.11). …”

Supplementary file 3_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx by Yi-Chang Zhao (14080107)

“…Adverse reactions showed a non-significant reduction (RR = 0.65; 95% CI: 0.38–1.11). …”

Supplementary file 1_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx by Yi-Chang Zhao (14080107)

“…Adverse reactions showed a non-significant reduction (RR = 0.65; 95% CI: 0.38–1.11). …”